# Palvella Therapeutics, Inc.: Form DEF 14A, filed Nov 6, 2024

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: DEF 14A
- Filed: 2024-11-06
- Accepted by EDGAR: Nov 6, 2024, 17:01 ET
- Period: 2024-12-02
- Accession: 0001437749-24-033669
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924033669/pirs20240304_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000143774924033669/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000143774924033669/pirs20240304_def14a.htm

Filed Nov 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-033669. Last ingested by Listed: Oct 28, 2026, 07:31 ET. No prices; not investment advice.